 Elizabeth Kozora
Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lupus Erythematosus, Systemic | 14 | 2022 | 227 | 3.710 |
Why?
| | Cognition Disorders | 15 | 2022 | 529 | 3.010 |
Why?
| | Neuropsychological Tests | 21 | 2022 | 1032 | 1.580 |
Why?
| | Cognition | 11 | 2022 | 1024 | 1.350 |
Why?
| | Depression | 6 | 2011 | 1132 | 0.850 |
Why?
| | Antiphospholipid Syndrome | 4 | 2016 | 29 | 0.850 |
Why?
| | Coronary Artery Bypass | 5 | 2019 | 209 | 0.830 |
Why?
| | Leukoencephalopathies | 2 | 2013 | 32 | 0.830 |
Why?
| | Antibodies, Antiphospholipid | 3 | 2016 | 22 | 0.640 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 6 | 2021 | 1137 | 0.610 |
Why?
| | Emphysema | 3 | 2011 | 123 | 0.610 |
Why?
| | Pulmonary Emphysema | 2 | 2011 | 327 | 0.570 |
Why?
| | Coronary Artery Bypass, Off-Pump | 6 | 2017 | 15 | 0.550 |
Why?
| | Memory Disorders | 4 | 2017 | 168 | 0.540 |
Why?
| | Cognitive Dysfunction | 4 | 2021 | 301 | 0.510 |
Why?
| | Lupus Vasculitis, Central Nervous System | 3 | 2018 | 6 | 0.500 |
Why?
| | Pneumonectomy | 2 | 2011 | 115 | 0.450 |
Why?
| | Trail Making Test | 1 | 2011 | 5 | 0.420 |
Why?
| | Attention | 4 | 2019 | 408 | 0.350 |
Why?
| | Memory | 5 | 2010 | 230 | 0.330 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2010 | 191 | 0.330 |
Why?
| | Antibodies | 1 | 2010 | 392 | 0.310 |
Why?
| | Smoking | 3 | 2020 | 1487 | 0.300 |
Why?
| | Executive Function | 4 | 2022 | 391 | 0.300 |
Why?
| | Middle Aged | 21 | 2020 | 27617 | 0.270 |
Why?
| | Fatigue | 2 | 2011 | 297 | 0.270 |
Why?
| | Nervous System Diseases | 1 | 2008 | 261 | 0.270 |
Why?
| | Quality of Life | 4 | 2021 | 2366 | 0.260 |
Why?
| | Anxiety | 2 | 2011 | 845 | 0.250 |
Why?
| | Humans | 38 | 2022 | 118972 | 0.240 |
Why?
| | Carotid Arteries | 2 | 2021 | 184 | 0.210 |
Why?
| | Behavior | 1 | 2002 | 95 | 0.210 |
Why?
| | Female | 24 | 2020 | 61564 | 0.210 |
Why?
| | Male | 24 | 2020 | 57801 | 0.200 |
Why?
| | Memory, Short-Term | 2 | 2013 | 233 | 0.190 |
Why?
| | Choline | 3 | 2013 | 109 | 0.190 |
Why?
| | Graft Occlusion, Vascular | 2 | 2019 | 35 | 0.190 |
Why?
| | Psychometrics | 2 | 2017 | 631 | 0.190 |
Why?
| | Pain | 1 | 2006 | 735 | 0.190 |
Why?
| | Brain | 5 | 2018 | 2490 | 0.190 |
Why?
| | Verbal Behavior | 2 | 2013 | 48 | 0.180 |
Why?
| | Carotid Artery Diseases | 1 | 2020 | 58 | 0.180 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2013 | 508 | 0.170 |
Why?
| | Angina Pectoris | 1 | 2019 | 63 | 0.170 |
Why?
| | Smokers | 1 | 2019 | 149 | 0.170 |
Why?
| | Frontal Lobe | 2 | 2013 | 148 | 0.170 |
Why?
| | Treatment Outcome | 9 | 2019 | 9342 | 0.160 |
Why?
| | Magnetic Resonance Imaging | 5 | 2018 | 3174 | 0.160 |
Why?
| | Psychomotor Performance | 3 | 2011 | 290 | 0.160 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2021 | 231 | 0.150 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 252 | 0.150 |
Why?
| | Coronary Angiography | 1 | 2019 | 311 | 0.150 |
Why?
| | Adult | 11 | 2013 | 31512 | 0.150 |
Why?
| | Learning | 2 | 2013 | 374 | 0.140 |
Why?
| | Autoantibodies | 3 | 2018 | 1335 | 0.140 |
Why?
| | Single-Blind Method | 3 | 2011 | 269 | 0.140 |
Why?
| | Physical Endurance | 2 | 2010 | 231 | 0.140 |
Why?
| | Central Nervous System Diseases | 1 | 2016 | 64 | 0.130 |
Why?
| | Case-Control Studies | 4 | 2012 | 3171 | 0.130 |
Why?
| | Vascular Stiffness | 1 | 2020 | 425 | 0.130 |
Why?
| | Coronary Artery Disease | 2 | 2014 | 647 | 0.130 |
Why?
| | Rheumatology | 2 | 2006 | 87 | 0.120 |
Why?
| | Aged | 10 | 2020 | 19657 | 0.120 |
Why?
| | Coronary Circulation | 1 | 2014 | 121 | 0.120 |
Why?
| | Health Status Indicators | 2 | 2011 | 154 | 0.110 |
Why?
| | Motor Skills | 1 | 2013 | 85 | 0.110 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 82 | 0.110 |
Why?
| | Prospective Studies | 3 | 2019 | 6471 | 0.110 |
Why?
| | Follow-Up Studies | 4 | 2017 | 4596 | 0.100 |
Why?
| | Neurologic Examination | 2 | 2008 | 126 | 0.100 |
Why?
| | Creatinine | 1 | 2013 | 491 | 0.100 |
Why?
| | Postoperative Complications | 3 | 2014 | 2235 | 0.100 |
Why?
| | Linear Models | 2 | 2011 | 827 | 0.100 |
Why?
| | Immunologic Factors | 1 | 2013 | 225 | 0.100 |
Why?
| | Regression Analysis | 1 | 2013 | 983 | 0.090 |
Why?
| | Severity of Illness Index | 3 | 2019 | 2674 | 0.090 |
Why?
| | Forced Expiratory Volume | 1 | 2011 | 520 | 0.090 |
Why?
| | Cardiopulmonary Bypass | 1 | 2011 | 203 | 0.090 |
Why?
| | Acetylcholine | 1 | 2010 | 208 | 0.090 |
Why?
| | Aspartic Acid | 2 | 2009 | 86 | 0.090 |
Why?
| | Brain Chemistry | 2 | 2009 | 119 | 0.090 |
Why?
| | Neuroimaging | 1 | 2011 | 256 | 0.080 |
Why?
| | Pulmonary Fibrosis | 1 | 2011 | 303 | 0.080 |
Why?
| | Reproducibility of Results | 2 | 2006 | 2874 | 0.080 |
Why?
| | Muscle Strength | 1 | 2010 | 283 | 0.080 |
Why?
| | West Nile Fever | 1 | 2008 | 51 | 0.080 |
Why?
| | Coronary Disease | 1 | 2009 | 356 | 0.070 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2008 | 124 | 0.070 |
Why?
| | Adaptation, Psychological | 1 | 2011 | 557 | 0.070 |
Why?
| | Multiple Sclerosis | 2 | 2016 | 384 | 0.070 |
Why?
| | Hypoglycemic Agents | 1 | 2014 | 1032 | 0.070 |
Why?
| | Diabetes Mellitus | 1 | 2014 | 942 | 0.070 |
Why?
| | Prednisone | 1 | 2006 | 235 | 0.070 |
Why?
| | Ohio | 1 | 2005 | 141 | 0.070 |
Why?
| | Mental Processes | 1 | 2005 | 35 | 0.070 |
Why?
| | Reference Values | 1 | 2006 | 774 | 0.060 |
Why?
| | Longitudinal Studies | 1 | 2011 | 2513 | 0.060 |
Why?
| | Respiratory Function Tests | 2 | 2019 | 526 | 0.060 |
Why?
| | Lung | 2 | 2019 | 3664 | 0.060 |
Why?
| | Pain Measurement | 1 | 2006 | 469 | 0.060 |
Why?
| | Biomarkers | 1 | 2013 | 3588 | 0.060 |
Why?
| | Language | 1 | 2005 | 271 | 0.060 |
Why?
| | Vascular Patency | 2 | 2014 | 98 | 0.060 |
Why?
| | United States Department of Veterans Affairs | 2 | 2019 | 555 | 0.050 |
Why?
| | United States | 4 | 2019 | 12555 | 0.050 |
Why?
| | Kaplan-Meier Estimate | 2 | 2017 | 842 | 0.050 |
Why?
| | Carotid Artery, Common | 1 | 2021 | 30 | 0.050 |
Why?
| | Reaction Time | 2 | 2017 | 392 | 0.050 |
Why?
| | Risk Factors | 3 | 2020 | 9000 | 0.050 |
Why?
| | Hippocampus | 1 | 2005 | 735 | 0.050 |
Why?
| | Societies, Medical | 1 | 2004 | 703 | 0.050 |
Why?
| | Risk Assessment | 2 | 2020 | 3057 | 0.050 |
Why?
| | Time Factors | 3 | 2019 | 6412 | 0.040 |
Why?
| | Activities of Daily Living | 1 | 2021 | 354 | 0.040 |
Why?
| | Survival Rate | 2 | 2014 | 1720 | 0.040 |
Why?
| | Surveys and Questionnaires | 3 | 2021 | 4708 | 0.040 |
Why?
| | Blood-Brain Barrier | 1 | 2018 | 108 | 0.040 |
Why?
| | Self-Assessment | 1 | 2017 | 63 | 0.040 |
Why?
| | Pilot Projects | 2 | 2013 | 1419 | 0.040 |
Why?
| | Positron-Emission Tomography | 1 | 2018 | 298 | 0.040 |
Why?
| | Culture | 1 | 2017 | 129 | 0.040 |
Why?
| | Movement Disorders | 1 | 2016 | 45 | 0.030 |
Why?
| | Colorado | 1 | 2005 | 4196 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 649 | 0.030 |
Why?
| | Multivariate Analysis | 2 | 2012 | 1474 | 0.030 |
Why?
| | Brain Ischemia | 1 | 2018 | 310 | 0.030 |
Why?
| | Young Adult | 1 | 2010 | 10793 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 1868 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2019 | 1244 | 0.030 |
Why?
| | Age Factors | 1 | 2019 | 2995 | 0.030 |
Why?
| | Coronary Vessels | 1 | 2014 | 233 | 0.030 |
Why?
| | Rituximab | 1 | 2013 | 155 | 0.030 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 105 | 0.030 |
Why?
| | Adolescent | 1 | 2010 | 18480 | 0.030 |
Why?
| | Spiritualism | 1 | 2011 | 1 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 4552 | 0.020 |
Why?
| | Cytokines | 1 | 2018 | 1900 | 0.020 |
Why?
| | Religion | 1 | 2011 | 68 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 2012 | 418 | 0.020 |
Why?
| | Creatine | 1 | 2009 | 56 | 0.020 |
Why?
| | Health Resources | 1 | 2009 | 132 | 0.020 |
Why?
| | Mental Status Schedule | 1 | 2008 | 38 | 0.020 |
Why?
| | Inflammation | 1 | 2018 | 2566 | 0.020 |
Why?
| | Mental Disorders | 1 | 2016 | 939 | 0.020 |
Why?
| | Incidence | 1 | 2014 | 2424 | 0.020 |
Why?
| | Sleep Wake Disorders | 1 | 2011 | 241 | 0.020 |
Why?
| | Axons | 1 | 2009 | 185 | 0.020 |
Why?
| | Technology Assessment, Biomedical | 1 | 2007 | 29 | 0.020 |
Why?
| | Walking | 1 | 2011 | 415 | 0.020 |
Why?
| | Models, Statistical | 1 | 2011 | 636 | 0.020 |
Why?
| | Veterans | 1 | 2017 | 1208 | 0.020 |
Why?
| | Sample Size | 1 | 2007 | 133 | 0.020 |
Why?
| | Prevalence | 1 | 2012 | 2326 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2017 | 1798 | 0.020 |
Why?
| | Verbal Learning | 1 | 2005 | 74 | 0.020 |
Why?
| | Health Surveys | 1 | 2007 | 454 | 0.020 |
Why?
| | Safety | 1 | 2007 | 304 | 0.020 |
Why?
| | Research Design | 1 | 2007 | 969 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2014 | 12978 | 0.010 |
Why?
|
|
Kozora's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|